Cargando…
MiR-223 as a Regulator and Therapeutic Target in Liver Diseases
MicroRNAs (miRNAs) are endogenous non-coding single-stranded small molecule RNAs consisting of 20–24 nucleotides that are highly conserved in species evolution. Expression of miRNAs is strictly tissue-specific, and it is chronological in fungi and plants, as well as in animals. MiR-223 has been show...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965842/ https://www.ncbi.nlm.nih.gov/pubmed/35371024 http://dx.doi.org/10.3389/fimmu.2022.860661 |
_version_ | 1784678523032567808 |
---|---|
author | Gu, Jiarong Xu, Hao Chen, Yandong Li, Na Hou, Xin |
author_facet | Gu, Jiarong Xu, Hao Chen, Yandong Li, Na Hou, Xin |
author_sort | Gu, Jiarong |
collection | PubMed |
description | MicroRNAs (miRNAs) are endogenous non-coding single-stranded small molecule RNAs consisting of 20–24 nucleotides that are highly conserved in species evolution. Expression of miRNAs is strictly tissue-specific, and it is chronological in fungi and plants, as well as in animals. MiR-223 has been shown to play a key role in innate immunity, and dysregulation of its expression contributes to the pathogenesis of multiple inflammatory diseases, and cancers. In this article the biosynthesis and functions of miR-223 in innate immunity are reviewed, and the role of miR-223 in liver physiopathology and therapeutic prospects are highlighted. |
format | Online Article Text |
id | pubmed-8965842 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89658422022-03-31 MiR-223 as a Regulator and Therapeutic Target in Liver Diseases Gu, Jiarong Xu, Hao Chen, Yandong Li, Na Hou, Xin Front Immunol Immunology MicroRNAs (miRNAs) are endogenous non-coding single-stranded small molecule RNAs consisting of 20–24 nucleotides that are highly conserved in species evolution. Expression of miRNAs is strictly tissue-specific, and it is chronological in fungi and plants, as well as in animals. MiR-223 has been shown to play a key role in innate immunity, and dysregulation of its expression contributes to the pathogenesis of multiple inflammatory diseases, and cancers. In this article the biosynthesis and functions of miR-223 in innate immunity are reviewed, and the role of miR-223 in liver physiopathology and therapeutic prospects are highlighted. Frontiers Media S.A. 2022-03-16 /pmc/articles/PMC8965842/ /pubmed/35371024 http://dx.doi.org/10.3389/fimmu.2022.860661 Text en Copyright © 2022 Gu, Xu, Chen, Li and Hou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Gu, Jiarong Xu, Hao Chen, Yandong Li, Na Hou, Xin MiR-223 as a Regulator and Therapeutic Target in Liver Diseases |
title | MiR-223 as a Regulator and Therapeutic Target in Liver Diseases |
title_full | MiR-223 as a Regulator and Therapeutic Target in Liver Diseases |
title_fullStr | MiR-223 as a Regulator and Therapeutic Target in Liver Diseases |
title_full_unstemmed | MiR-223 as a Regulator and Therapeutic Target in Liver Diseases |
title_short | MiR-223 as a Regulator and Therapeutic Target in Liver Diseases |
title_sort | mir-223 as a regulator and therapeutic target in liver diseases |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965842/ https://www.ncbi.nlm.nih.gov/pubmed/35371024 http://dx.doi.org/10.3389/fimmu.2022.860661 |
work_keys_str_mv | AT gujiarong mir223asaregulatorandtherapeutictargetinliverdiseases AT xuhao mir223asaregulatorandtherapeutictargetinliverdiseases AT chenyandong mir223asaregulatorandtherapeutictargetinliverdiseases AT lina mir223asaregulatorandtherapeutictargetinliverdiseases AT houxin mir223asaregulatorandtherapeutictargetinliverdiseases |